BAG-1 protein predicts breast cancer prognosis
This article was originally published in Clinica
A research team has discovered what it claims could become one of the most powerful markers for predicting the long-term survival of women with early breast cancer.
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.